Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

7.09
Delayed Data
As of Apr 24
 -0.24 / -3.27%
Today’s Change
4.07
Today|||52-Week Range
12.88
-24.49%
Year-to-Date

Today’s Trading

Previous close7.33
Today’s open7.36
Day’s range7.03 - 7.50
Volume1,123,340
Average volume (3 months)893,582
Market cap$281.4M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)+7.53%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book3.36

Competitors

 Today’s
change
Today’s
% change
AMBIAmbit Biosciences Co...----
NHTCNatural Health Trend...+0.05+0.22%
SVASinovac Biotech Ltd0.000.00%
--China Health Group I...-0.02-4.62%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 1, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers